Erick Alexanderson-Rosas

Erick Alexanderson-Rosas


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2023 in International Journal of Cardiovascular Sciences
Verified
Journal Article
Open access
PDF file
AGAna Gilabert-Garcia
Ana Gilabert-Garcia
CGCristina Cristina Villarreal Guerrero
Cristina Cristina Villarreal Guerrero
RDRodrigo Dagio-Cuéllar
Rodrigo Dagio-Cuéllar
JBJorge Luis Bermudez-Gonzalez
Jorge Luis Bermudez-Gonzalez
APArantza Marie Perez-Partida
Arantza Marie Perez-Partida
EAErick Alexanderson-Rosas
Erick Alexanderson-Rosas
Coronary artery disease (CAD) and ischemic heart disease (IHD) are often indistinctly used terms. Both combined have generated, over the past years, concerns about sex disparities in their presentation. From an epidemiological perspective, females have several disadvantages regarding the prevention, diagnosis, and treatment of CAD. Most of the general cardiovascular risk factors affect women more frequently, or with a higher morbidity and mortality association. Besides, atypical manifestations of the disease and uncommon forms of CAD represent a diagnostic challenge [...] Abstract Coronary artery disease (CAD) and ischemic heart disease (IHD) are often indistinctly used terms. Both combined have generated, over the past years, concerns about sex disparities in their presentation. From an epidemiological perspective, females have several disadvantages regarding the prevention, diagnosis, and treatment of CAD. Most of the general cardiovascular risk factors affect women more frequently, or with a higher morbidity and mortality association. Besides, atypical manifestations of the disease and uncommon forms of CAD represent a diagnostic challenge

17 November 2023 in Clinical Case Reports
Verified
Journal Article
Open access
RVRaúl Velázquez‐Castañeda
Raúl Velázquez‐Castañeda
IPIlana De La Puente‐Tawil
Ilana De La Puente‐Tawil
SMSofía Molina‐Castillo
Sofía Molina‐Castillo
LPLeonardo Proaño‐Bernal
Leonardo Proaño‐Bernal
MRMariell Alejandra Rodríguez‐Salazar
Mariell Alejandra Rodríguez‐Salazar
VAVincenzo Arenas‐Fabbri
Vincenzo Arenas‐Fabbri
Key Clinical Message: Coronary artery fistula is a rare abnormal connection between the heart arteries. Patients may remain asymptomatic until adulthood, potentially experiencing life‐threatening complications. Adequate monitoring and therapeutic management are essential.

1 April 2023 in Journal of Nuclear Cardiology
Verified
Journal Article
Closed access
PDF file
JBJorge Luis Bermudez-Gonzalez
Jorge Luis Bermudez-Gonzalez
MGMiguel Angel Gonzalez-Hernandez
Miguel Angel Gonzalez-Hernandez
LPLeonardo Proaño-Bernal
Leonardo Proaño-Bernal
AGAna Gilabert-García
Ana Gilabert-García
CVCristina Villarreal-Guerrero
Cristina Villarreal-Guerrero
EAErick Alexanderson-Rosas
Erick Alexanderson-Rosas

31 December 2025 in medRxiv
Verified
Preprint
Open access
PDF file
LJLee Joseph
Lee Joseph
LTLudovic Trinquart
Ludovic Trinquart
DLDiana M. Lopez
Diana M. Lopez
SBSimone Soares Brandao
Simone Soares Brandao
JBJenifer M. Brown
Jenifer M. Brown
MCMarcelo F. Di Carli
Marcelo F. Di Carli
Introduction: Positron emission tomography (PET) myocardial flow reserve (MFR) is a robust indicator of coronary vascular health and a strong predictor of cardiovascular risk. Clinical guidelines typically use fixed MFR thresholds (e.g., <2.0) to stratify risk, yet this approach overlooks individual variation, particularly by age and sex. We aimed to establish age- and sex-adjusted MFR percentiles and to evaluate their prognostic and predictive performance for cardiovascular risk assessment, in comparison with conventional fixed-threshold MFR approach. Methods: Using data from the REFINE PET registry (24,820 patients from 12 sites), we measured PET MFR and derived age- and sex-adjusted MFR reference percentiles using quantile regression in patients without known coronary artery disease. All patients were categorized into percentile-based quartile groups. The primary outcome for prognostic and prediction analyses was major adverse cardiovascular events (MACE), defined as all-cause mortality, myocardial infarction, or heart-failure hospitalization. Time-to-event associations were evaluated using covariate-adjusted survival models, with cumulative incidence and hazard ratios (HR) estimated at 1 and 5 years in the derivation dataset, an independent but similar validation dataset A, and a high-risk validation dataset B. Predictive performance for MACE was assessed using discrimination, calibration, and reclassification metrics, comparing percentile-based models with models using a fixed MFR threshold (2.0), cardiovascular risk increased steadily across MFR percentiles even within this range. Conclusion: Age- and sex-adjusted MFR percentiles provide a reliable, clinically actionable measure of vascular health, improving cardiovascular risk stratification by better capturing age- and sex-related heterogeneity in vascular risk. Compared with traditional fixed-threshold approaches, MFR percentiles demonstrate improved predictive performance for cardiovascular risk assessment across diverse patient populations. CLINICAL PERSPECTIVE: What is new?: In a large, multinational real-world registry of more than 24,000 patients undergoing PET MPI, we derived age- and sex-adjusted myocardial flow reserve (MFR) percentiles, establishing a lifespan-based reference framework with age-specific reference values. Age- and sex-adjusted MFR percentiles showed a strong, graded association with 1- and 5-year cardiovascular risk and demonstrated improved prognostic and predictive performance compared with fixed MFR thresholds and models without MFR across independent derivation and validation datasets, including a higher-risk cohort. Lower adjusted MFR percentiles were consistently associated with higher risk of major adverse cardiovascular events, including all-cause mortality, myocardial infarction, and heart-failure hospitalization. What are the clinical implications?: Age- and sex-adjusted MFR percentiles provide a personalized, dynamic measure of coronary vascular health that improves cardiovascular risk stratification by accounting for age- and sex-related heterogeneity. A percentile-based approach may help clinicians better identify patients at elevated cardiovascular risk who may warrant closer monitoring or intensified preventive strategies, while avoiding unnecessary intervention in lower-risk individuals. By integrating macrovascular and microvascular dysfunction, age- and sex-adjusted MFR percentiles offer a clinically interpretable marker of vascular aging that may inform future research on aging biomarkers, novel therapeutics and cardiovascular risk assessment across the spectrum of atherosclerotic and microvascular disease.

1 January 2021 in Clinical Research and Trials
Verified
Journal Article
Open access
CACesar Rodrigo Arce-Sandoval
Cesar Rodrigo Arce-Sandoval
LZLilian Zavala-Romero
Lilian Zavala-Romero
RRRodrigo Enrique Romero-Montiel
Rodrigo Enrique Romero-Montiel
SASergio Asch-Abadi
Sergio Asch-Abadi
HGHector Gurrola-Luna
Hector Gurrola-Luna
EAErick Alexanderson-Rosas
Erick Alexanderson-Rosas
OA Text is an independent open-access scientific publisher showcases innovative research and ideas aimed at improving health by linking research and practice to the benefit of society.

1 March 2022 in Journal of Nuclear Cardiology
Verified
Journal Article
Closed access
PDF file
ASAldo Hugo Santoyo-Saavedra
Aldo Hugo Santoyo-Saavedra
NENilda Espinola-Zavaleta
Nilda Espinola-Zavaleta
JBJorge Luis Bermudez-Gonzalez
Jorge Luis Bermudez-Gonzalez
MGMiguel Ángel Gonzalez-Hernandez
Miguel Ángel Gonzalez-Hernandez
MGMauricio García-Cárdenas
Mauricio García-Cárdenas
EAErick Alexanderson-Rosas
Erick Alexanderson-Rosas